RÉDOVÁ, Martina, Alexandr POPRACH, Jana NEKVINDOVÁ, Robert ILIEV, Lenka RADOVÁ, Radek LAKOMÝ, Marek SVOBODA, Rostislav VYZULA a Ondřej SLABÝ. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. Journal of Translational Medicine. London: Biomed Central, 2012, roč. 10, March, s. "nestránkováno", 8 s. ISSN 1479-5876. Dostupné z: https://dx.doi.org/10.1186/1479-5876-10-55. |
Další formáty:
BibTeX
LaTeX
RIS
@article{984202, author = {Rédová, Martina and Poprach, Alexandr and Nekvindová, Jana and Iliev, Robert and Radová, Lenka and Lakomý, Radek and Svoboda, Marek and Vyzula, Rostislav and Slabý, Ondřej}, article_location = {London}, article_number = {March}, doi = {http://dx.doi.org/10.1186/1479-5876-10-55}, keywords = {Renal cell carcinoma; MicroRNA; Serum; Biomarker}, language = {eng}, issn = {1479-5876}, journal = {Journal of Translational Medicine}, title = {Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma}, url = {http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/?tool=pubmed}, volume = {10}, year = {2012} }
TY - JOUR ID - 984202 AU - Rédová, Martina - Poprach, Alexandr - Nekvindová, Jana - Iliev, Robert - Radová, Lenka - Lakomý, Radek - Svoboda, Marek - Vyzula, Rostislav - Slabý, Ondřej PY - 2012 TI - Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma JF - Journal of Translational Medicine VL - 10 IS - March SP - "nestránkováno" EP - "nestránkováno" PB - Biomed Central SN - 14795876 KW - Renal cell carcinoma KW - MicroRNA KW - Serum KW - Biomarker UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/?tool=pubmed L2 - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340316/?tool=pubmed N2 - There is no standard serum biomarker used for diagnosis or early detection of recurrence for renal cell carcinoma (RCC) patients. MicroRNAs (miRNAs) are abundant and highly stable in blood serum, and have been recently described as powerful circulating biomarkers in a wide range of solid cancers. Our aim was to identify miRNA signature that can distinguish the blood serum of RCC patients and matched healthy controls and validate identified miRNAs as potential biomarkers for RCC. ER -
RÉDOVÁ, Martina, Alexandr POPRACH, Jana NEKVINDOVÁ, Robert ILIEV, Lenka RADOVÁ, Radek LAKOMÝ, Marek SVOBODA, Rostislav VYZULA a Ondřej SLABÝ. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. \textit{Journal of Translational Medicine}. London: Biomed Central, 2012, roč.~10, March, s.~''nestránkováno'', 8 s. ISSN~1479-5876. Dostupné z: https://dx.doi.org/10.1186/1479-5876-10-55.
|